Carlos Oyarzun

From WikiMD's Wellness Encyclopedia

Carlos Oyarzun
Personal information
Full nameCarlos Iván Oyarzun Guiñez
BornBirth date -1st March 1966
Santiago, Chile
Team information
Current teamRetired
DisciplineRoad
RoleRider
Professional teams
2006–2007Viña Magna-Cropu
2008Benfica
2009Rock Racing
2010Doğuş Hastanesi
2011Movistar Team Continental
2012Caja Rural
2013–2015Louletano-Dunas Douradas

Script error: No such module "Infobox cyclist tracking".


Carlos Iván Oyarzun Guiñez (born October 26, 1981, in Santiago, Chile) is a retired Chilean professional road cyclist. He competed professionally from 2006 to 2015 for various teams, including Benfica and Caja Rural.

Career[edit | edit source]

Carlos Oyarzun began his professional cycling career in 2006 with the Spanish team Viña Magna-Cropu. Over the years, he rode for several other teams, showcasing his abilities in various international competitions. Notably, Oyarzun was part of the Movistar Team Continental in 2011, a development team for the main Movistar Team.

In 2015, while riding for Louletano-Dunas Douradas, Oyarzun tested positive for a banned substance during the Pan American Games. As a result, he was disqualified from the games and subsequently faced a suspension from professional cycling.

Major Results[edit | edit source]

  • 2009 - 1st, National Time Trial Championship
  • 2011 - 1st, National Time Trial Championship
  • 2013 - 1st, National Time Trial Championship

Controversy[edit | edit source]

In July 2015, during the Pan American Games, Oyarzun was found to have used a banned performance-enhancing drug. This led to his immediate removal from the competition and a tarnished reputation in the cycling community. Following this incident, Oyarzun faced a lengthy ban, which significantly impacted his professional career.

Post-Cycling Career[edit | edit source]

After retiring from professional cycling, Carlos Oyarzun has kept a low profile. Details regarding his post-cycling endeavors remain limited.

See Also[edit | edit source]

Contributors: Prab R. Tumpati, MD